![Ryan Swanson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Ryan Swanson
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 19 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ryan Swanson
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
Alpine Bioventures, GP, LLC
![]() Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Investment Managers | Founder Private Equity Investor Private Equity Investor Private Equity Investor | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Director/Board Member Corporate Officer/Principal Graduate Degree | |
SillaJen Biotherapeutics, Inc.
![]() SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Sales & Marketing | |
ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Frazier Management LLC
![]() Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
EDGEWISE THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Founder | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ClinOne, Inc.
![]() ClinOne, Inc. Packaged SoftwareTechnology Services ClinOne, Inc. develops mobile software application. The firm serves for sites and patients. It offers elaerning, screening, documents, videos, econsent, procedure manager, and adverse events services. The company was founded by Rob Bohacs and Eric Schraufnagel and is headquartered in Denver, CO. | Packaged Software | Chairman Director of Finance/CFO | |
IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Varro Technologies, Inc.
![]() Varro Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Varro Technologies, Inc. develops distributed knowledge management applications for the life science industry. It offers a patent-pending technology solution for accessing, managing, and sharing the genetic information. The company was founded by Jay Venkatesan, David Sullivan Shin, Wesley Chan, and Chester M Hedgepeth III on December 22, 2000 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Founder | |
REVA MEDICAL INC | Medical Specialties | Director/Board Member | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ACM Capital Partners LLC
![]() ACM Capital Partners LLC Investment ManagersFinance ACM Capital Partners LLC provides investments services. The company is headquartered in Miami, FL. | Investment Managers | Corporate Officer/Principal | |
Williams College | College/University | Undergraduate Degree | |
Brookside Mezzanine Partners Management LLC
![]() Brookside Mezzanine Partners Management LLC Investment ManagersFinance Brookside Mezzanine Partners Management LLC (Brookside Capital Partners) is a private equity firm founded in 1977 by John N Irwin and David D Buttolph. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Director/Board Member | |
Ayer Capital Partners Master Fund LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Bain Capital Public Equity LP
![]() Bain Capital Public Equity LP Investment ManagersFinance Bain Capital Public Equity LP is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1996 as Brookside Capital LP. They are wholly-owned by Bain Capital LP, itself a subsidiary of Bain Capital Holdings LP. Bain Capital Public Equity provides investment advisory services to pooled investment vehicles (Public Equity Funds). Investors in the Public Equity Funds includes high net-worth individuals, banks, thrift institutions, pension and profit sharing plans, trusts, estates, charitable organizations, university endowments, corporations, limited partnerships and limited liability companies or other business entities. | Investment Managers | Portfolio Manager-Equities | |
Tangerine Technologies, Inc.
![]() Tangerine Technologies, Inc. Packaged SoftwareTechnology Services Tangerine Technologies, Inc. provides software development and business process outsourcing solutions. The company was founded by Jay Venkatesan and Todd Riley Johnson in 1999 and is headquartered in Santa Clara, CA. | Packaged Software | Founder | |
Transplant Genomics, Inc.
![]() Transplant Genomics, Inc. BiotechnologyHealth Technology Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA. | Biotechnology | Director/Board Member | |
EXICURE, INC. | Biotechnology | Director/Board Member | |
Cell Biotherapy, Inc.
![]() Cell Biotherapy, Inc. BiotechnologyHealth Technology Cell Biotherapy, Inc. develops bio therapeutics. The American company was founded by Michael E. Meyers and he has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Alpine Bioventures LP
![]() Alpine Bioventures LP Investment ManagersFinance Alpine Bioventures LP invests in companies located in the United States. The fund targets companies operating in the fields of science and healthcare services. It provides financing for seed and early stage capital requirements. It also makes co-investments. | Investment Managers | Founder | |
ELICIO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Zylem Biosciences, Inc. | Biotechnology | Founder | |
University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Founder | |
Curevo, Inc.
![]() Curevo, Inc. BiotechnologyHealth Technology Curevo, Inc. is a clinical stage company based in South Korea that aims to bring next generation vaccines to the market quickly and efficiently. The company is based in Seattle, WA. The company's partners include Mogam Institute for Biomedical Research and GC Pharma. Curevo is currently in phase 2 of a shingles study to evaluate the safety, tolerability, and immunogenicity of their vaccine. The company's goal is to reduce the burden of infectious disease with a focus on safe and highly effective shingles and varicella vaccines. Curevo was founded in 2018, and the CEO is George Simeone. | Biotechnology | Corporate Officer/Principal | |
Newyu, Inc.
![]() Newyu, Inc. Medical/Nursing ServicesHealth Services Newyu, Inc. provides web-based health information services. It offers implementation, ongoing account management and customer support services. The company serves those monitoring asthma, diabetes, pulmonary disease, hypertension, cardiovascular disease and congestive heart failure. iMetrikus was founded by William J. Rutter in 1998 and is headquartered in Carlsbad, CA. | Medical/Nursing Services | Chief Executive Officer | |
Cardioxyl Pharmaceuticals LLC
![]() Cardioxyl Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardioxyl Pharmaceuticals, Inc. discovers and develops therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded by Vincent J. Kalish and Douglas Cowart in 2005 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Director/Board Member | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Chairman | |
Cleave Therapeutics, Inc.
![]() Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Founder | |
Strategicon Partners | Founder | ||
RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Chairman | |
MIRATI THERAPEUTICS | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 48 |
Israel | 2 |
Cayman Islands | 2 |
Kanada | 2 |
Sektoral
Health Technology | 27 |
Finance | 9 |
Commercial Services | 7 |
Consumer Services | 6 |
Technology Services | 3 |
Operativ
Director/Board Member | 180 |
Corporate Officer/Principal | 55 |
Independent Dir/Board Member | 42 |
Founder | 29 |
Chairman | 29 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Paul Sekhri | 62 |
James Topper | 52 |
Peter Thompson | 39 |
Xiang Ming Cui | 31 |
Jay Venkatesan | 30 |
Robert Conway | 21 |
R. Carruthers | 15 |
Mitchell Gold | 15 |
Mark Litton | 11 |
Christopher Peetz | 11 |
Stanford Peng | 9 |
Jon Congleton | 8 |
James Rickey | 8 |
Remy Durand | 7 |
David Miller | 6 |
- Börse
- Insiders
- Ryan Swanson
- Unternehmensverbindungen